Dementia (Diagnosis)

4

Review clinical trials related to Dementia (Diagnosis). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)

The goal of this observational study is to learn if an artificial intelligence (AI)-based speech analysis tool can identify which patients with memory problems need specialist evaluation at a memory clinic. The main questions it aims to answer are: Can the AI model accurately distinguish between patients who need referral to a memory clinic (those with dementia or Mild Cognitive Impairment) and patients who don't (those with normal cognition or memory problems from other causes like depression)? Which speech patterns and cognitive test features are most useful for making this distinction? Researchers will compare speech recordings and cognitive test results from patients diagnosed with dementia or MCI to those from patients with normal cognition or non-neurodegenerative cognitive impairment to see if the AI model can reliably predict who needs specialist dementia care. Participants will: Complete standard cognitive tests at the memory clinic Perform structured speech tasks while being audio-recorded Receive their usual clinical evaluation and diagnosis from memory clinic specialists The results of this study will help develop a tool that can assist doctors in making faster, more accurate decisions about which patients need specialist dementia evaluation, potentially leading to earlier diagnosis and better patient outcomes.

Participants needed: 440
Trial details
Age: 50+Biological sex: AllType: ObservationalSponsor: Zealand University HospitalUpdated: May 5, 2026Locations: 1
Eligibility criteria

Age > 50 years [+9]

Significantly impaired vision or hearing (to the extent that the patient cannot... [+16]

Status: Not yet recruiting

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.

This study aims to evaluate the efficacy of community-based early detection and targeted interventions, including stem cell therapy and wearable non-invasive brain-computer interface (BCI) devices, for Mild Cognitive Impairment (MCI) in adults aged 55 years and older residing in U.S. urban and suburban communities. Primary objectives include assessing improvements in MCI detection rates, cognitive outcomes, and progression delay compared to standard care.

Participants needed: 600
Trial details
Phase: Early Phase 1Age: 55+Biological sex: AllType: InterventionalSponsor: Noah Tech, Corp.Updated: Mar 10, 2026Locations: 1
Eligibility criteria

Not listed

Status: Not yet recruiting

Loneliness as Risk Factor for Dementia

This study aims to determine whether loneliness is associated with a higher incidence of dementia in older adults with a prior diagnosis of mild cognitive impairment after 12 months of follow-up.

Participants needed: 300
Trial details
Age: 70+Biological sex: AllType: ObservationalSponsor: Consorci Sanitari de l'Alt Penedès i GarrafUpdated: Nov 26, 2025Locations: 1
Eligibility criteria

Not listed

Status: Not yet recruiting

Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease

Dementia is observed in 80% of people living with advanced stage Parkinson's disease, however, there are inadequate opportunities for early and effective diagnosis of dementia in current clinical practice. This study aims to identify whether a new tool called PDCogniCare, can improve detection of dementia in people living with Parkinson's disease, and to explore what factors might influence its use in healthcare services.

Participants needed: 275
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: The University of QueenslandUpdated: Aug 11, 2025
Eligibility criteria

People living with idiopathic Parkinson's disease, one year or more post-diagnos...

People with severe Parkinson's disease who aren't able to communicate [+1]